Table 4.
Expression (%) of CD markers on the surface of HVS-transformed T-cell lines from gastric cancer patients and healthy volunteer controls; n number of patients or volunteers tested. Only relevant results are shown. See text for a complete list of markers studied
| Surface marker | Cancer patients (mean ± SEM) | Controls (mean ± SEM) |
|---|---|---|
| CD3+ | 90 ± 5 (n=7)* | 98 ± 1 (n=15) |
| CD45+ | 97 ± 2 (n=7)* | 100 ± 0 (n=10) |
| HLA-DR+ | 37 ± 6 (n=7)** | 69 ± 6 (n=13) |
*p<0.05; **p<0.01; ***p<0.001